Abstract:Schwann cells are critical for the proper development and function of the peripheral nervous system, where they form a mutually beneficial relationship with axons. Past studies have highlighted that a pair of proteins called the prohibitins play major roles in Schwann cell biology. Prohibitins are ubiquitously expressed and versatile proteins. We have previously shown that while prohibitins play a crucial role in Schwann cell mitochondria for long-term myelin maintenance and axon health, they may also be present at the Schwann cell-axon interface during development. Here, we expand on this work, showing that drug-mediated modulation of prohibitins disrupts myelination and confirming that Schwann cell-specific ablation of prohibitin 2 ( ) results in early and severe defects in peripheral nerve development. Using a proteomic approach , we identify a pool of candidate PHB2 interactors that change their interaction with PHB2 depending on the presence of axonal signals. Furthermore, we show that loss of in mouse Schwann cells causes ineffective proliferation and dysregulation of transcription factors EGR2 (KROX20), POU3F1 (OCT6) and POU3F2 (BRN2) that are necessary for proper Schwann cell maturation. Schwann cell-specific deletion of , a transcription factor associated with negative regulation of myelination, confers partial rescue of the development defect seen in mice lacking Schwann cell . This work develops our understanding of Schwann cell biology, revealing that may directly or indirectly modulate the timely expression of transcription factors necessary for proper peripheral nervous system development, and proposing candidates that may play a role in PHB2-mediated integration of axon signals in the Schwann cell.

What problem does this paper attempt to address?

The paper attempts to address the role of Prohibitin 2 (PHB2) in Schwann cells and its impact on peripheral nerve development. Specifically, the study found: 1. **Function of PHB2 in Schwann cells**: The paper demonstrates that drug-mediated regulation of PHB2 affects myelination, and in vivo experiments confirm that Schwann cell-specific knockout of PHB2 leads to early and severe peripheral nerve development defects. 2. **Changes in protein interactions**: Through in vitro experiments, researchers identified a set of candidate proteins whose interactions with PHB2 change in the presence of axonal signals. 3. **Regulation of transcription factors**: In vivo experiments show that the loss of PHB2 in Schwann cells leads to dysregulation of transcription factors EGR2 (KROX20), POU3F1 (OCT6), and POU3F2 (BRN2), which are crucial for the normal maturation of Schwann cells. 4. **Role of JUN**: The study also found that knocking out JUN (a transcription factor typically associated with negative regulation of myelination) in Schwann cells can partially rescue the developmental defects in PHB2-deficient mice. In summary, the paper aims to reveal how PHB2 directly or indirectly regulates the timely expression of transcription factors to promote normal development of the peripheral nervous system and proposes candidate proteins that may be involved in the integration of axonal signals.

Loss of prohibitin 2 in Schwann cells dysregulates key transcription factors controlling developmental myelination